Body · Medically-supervised weight loss
Saxenda (liraglutide)
A once-daily prescription injection. Lower-key dose schedule than the weekly options.
What it is
Saxenda is the brand name for liraglutide, a once-daily prescription injection. It was the first GLP-1 medication licensed for weight management in the UK and has the longest real-world track record in this class.
Saxenda is taken every day, which suits clients who prefer a daily routine to a weekly one. Trial data shows around 5–10% weight loss at 56 weeks, which is more modest than Mounjaro or Wegovy but still clinically meaningful.
What it treats
- Adults with a BMI ≥ 30
- Adults with a BMI ≥ 27 plus a weight-related health condition
- Adolescents aged 12–17 with obesity, under specialist care
How it works
- 1 Initial consultation with our prescriber.
- 2 Starting dose of 0.6 mg once daily, titrating weekly to a maintenance dose of 3 mg.
- 3 Daily self-injection, monthly clinic reviews.
- 4 Dispensed by our partnered GPhC-registered pharmacy.
What to expect
Appointment time
Daily self-injection at home. Monthly clinic review.
Downtime
None medically.
How it feels
A small subcutaneous needle, once a day.
Aftercare
Inject at the same time each day, vary site.
Results visible
From week 2–3 onward
How long they last
Ongoing while medication is appropriate
Is this right for you?
A good fit if
- You prefer a daily routine to a weekly one
- You meet the prescribing criteria
- You're prepared to combine with diet and lifestyle changes
Not the right time if
- You're pregnant, breastfeeding or planning to become pregnant
- You have a personal or family history of medullary thyroid cancer or MEN2
- You have a history of pancreatitis
Price
From £210 per month at maintenance dose
Final price confirmed in your complimentary consultation. Cancellation policy.
FAQs
Why daily instead of weekly?
Saxenda is a shorter-acting molecule. Some clients prefer the daily ritual; others find the weekly options easier to maintain. There's no clinical right answer — it depends on you.
Is Saxenda less effective?
On average, results are more modest than the weekly options — around 5–10% of body weight at 56 weeks. For some clients that is exactly the right amount; for others, the stronger options are a better fit.
Why does it have the longest track record?
Saxenda was the first GLP-1 licensed for weight management in the UK. Liraglutide as a molecule has been used in diabetes care for longer than the newer once-weekly options.
Related treatments
Mounjaro (tirzepatide)
Once-weekly GLP-1 / GIP injection — currently the strongest weight-loss data.
Learn more
Wegovy (semaglutide)
Once-weekly GLP-1 injection — well-established and widely used.
Learn more
Medically-supervised weight loss
GLP-1 medications (Mounjaro, Wegovy, Saxenda) prescribed and supervised.
Learn moreReady when you are
Start with a complimentary consultation.
Thirty minutes, in person, at Knightsbridge or Harley Street. We'll listen, look, and tell you honestly what we'd recommend — and what we wouldn't.